Home › Funds › PERCEPTIVE ADVISORS LLC › STRO
PERCEPTIVE ADVISORS LLC position in STRO
SUTRO BIOPHARMA INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 1,304,846 shares of STRO (SUTRO BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$43.3M, representing 0.69% of its reported portfolio and ranking #32 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's STRO position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in STRO in Q1 2026 at 715,307 shares (US$17.8M). The position peaked in Q2 2026 at 1,304,846 shares, worth US$43.3M. Across 2 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,304,846 shares valued at US$43.3M — an increase of 589,539 shares quarter over quarter.. Notable position changes include a 82% increase in Q2 2026 (shares fell 51% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 715.31K | $17.82M | New |
| Q2 2026 | 1.30M | $43.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STRO and 13F data
STRO (SUTRO BIOPHARMA INC) is a Health Care company. 45 other funds we track also report a position in STRO — the largest reported positions include BVF INC/IL (US$41.6M), Affinity Asset Advisors, LLC (US$38.9M), Samsara BioCapital, LLC (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STRO
- BVF INC/IL 1.25M sh · $41.56M · Q2 2026
- Affinity Asset Advisors, LLC 1.17M sh · $38.93M · Q2 2026
- Samsara BioCapital, LLC 1.06M sh · $35.29M · Q2 2026
- Kynam Capital Management, LP 872.56K sh · $28.97M · Q2 2026
- Velan Capital Investment Management LP 512.16K sh · $17.00M · Q2 2026
- ADAR1 Capital Management, LLC 404.01K sh · $13.41M · Q2 2026
- Merck & Co., Inc. 272.35K sh · $9.04M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 270.25K sh · $8.97M · Q2 2026
- KVP Capital Advisors, LP 226.57K sh · $7.52M · Q2 2026
- Seven Fleet Capital Management LP 159.12K sh · $3.79M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held STRO?
PERCEPTIVE ADVISORS LLC has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is PERCEPTIVE ADVISORS LLC's current position in STRO?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.30M shares of STRO (SUTRO BIOPHARMA INC), valued at $43.32M, representing 0.69% of its reported portfolio and ranking #32.
Has PERCEPTIVE ADVISORS LLC been buying or selling STRO?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in STRO. The position peaked in Q2 2026 at 1.30M shares.
Which other funds hold STRO?
Other major institutional holders of STRO include BVF INC/IL, Affinity Asset Advisors, LLC, Samsara BioCapital, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.